<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="164903">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02028897</url>
  </required_header>
  <id_info>
    <org_study_id>SAIRB-13-0040</org_study_id>
    <nct_id>NCT02028897</nct_id>
  </id_info>
  <brief_title>Comparison of Alternative Embryo Culture Systems</brief_title>
  <official_title>Comparison of Alternative Embryo Culture Systems</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bruce Shapiro M.D.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fertility Center of Las Vegas</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare two alternative embryo culture systems.  Embryos from each patient
      will be randomly assigned to one of two systems.  One group will be cultured conventionally
      in oil-covered droplets in dishes.  The other group will be assigned to an enclosed system.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Qualifying and consenting IVF patients will have approximately half of their developing
      embryos cultured in droplets covered with oil.  The other approximate half of their embryos
      will be cultured in small enclosed containers.  Embryo assignments will be at random.
      Regardless of culture system, all embryos will be cultured from the bipronuclear stage to
      the blastocyst stage in the same (Global) media, without the usual refreshing of media on
      day 3.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Blastulation rate</measure>
    <time_frame>5 days (sixth day of embryo development)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Proportion of cultured embryos that form blastocysts.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blastocyst morphology</measure>
    <time_frame>5 days (sixth day of development)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Inner cell mass size, number of trophectoderm cells, blastocyst diameter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IVF outcome</measure>
    <time_frame>7 weeks post-transfer</time_frame>
    <safety_issue>No</safety_issue>
    <description>The result of the IVF cycle as no pregnancy, early pregnancy loss, or ongoing pregnancy at 10 weeks gestation (about 7 weeks post-transfer).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">73</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Conventional embryo culture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional embryo culture in dishes, in droplets under oil.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Alternative embryo culture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Embryo culture in system using small enclosed containers</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional embryo culture</intervention_name>
    <arm_group_label>Conventional embryo culture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Enclosed embryo culture</intervention_name>
    <arm_group_label>Alternative embryo culture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female age 18 to 40, seeking IVF treatment

          -  Ability to understand English (to obtain informed consent)

          -  Use of an oocyte donor, sperm donor, gestational carrier, and/or genetic testing
             (with blastocyst biopsy only) are allowed.

        Exclusion Criteria:

          -  Diminished ovarian reserve as evidenced by either elevated cycle day 3 follicle
             stimulating hormone (FSH) level (â‰¥10 IU/L) or low antral follicle count (&lt;8 antral
             follicles)

          -  Fewer than five (5) bipronuclear oocytes

          -  Day 3 embryo biopsy for any reason

          -  No minors may enroll
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruce Shapiro, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fertility Center of Las Vegas</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arlyn Garcia</last_name>
    <phone>702-254-1777</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Fertility Center of Las Vegas</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Arlyn Garcia</last_name>
      <phone>702-254-1777</phone>
    </contact>
    <investigator>
      <last_name>Bruce Shapiro, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Said Daneshmand, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 7, 2014</lastchanged_date>
  <firstreceived_date>January 6, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Fertility Center of Las Vegas</investigator_affiliation>
    <investigator_full_name>Bruce Shapiro M.D.</investigator_full_name>
    <investigator_title>Medical Director</investigator_title>
  </responsible_party>
  <keyword>In vitro fertilization</keyword>
  <keyword>IVF</keyword>
  <keyword>Embryo culture</keyword>
  <keyword>Blastocyst transfer</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
